NKTR
NEKTAR THERAPEUTICS
+1.47 (+2.17%)68.85USD304K成交股數2.4B市值–本益比(近四季)43.1股價營收比-9.3%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0.00 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 3 · 441K · 2 |
| 其中 10b5-1 計畫賣出 | 1 筆 |
| 近 180 天 買進 · 賣出金額 | 0.00 · 2.0M |
| 近 180 天 淨額 | −2.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 | 08-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 186 | 71.98 | 13K | 9.6K | SEC |
| 2026-08-18 | 08-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 418 | 71.98 | 30K | 54.6K | SEC |
| 2026-06-30 | 07-02 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 5.7K | 70.00 | 398K | 9.8K | SEC |
| 2026-06-17 | 06-18 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 4.5K | 61.65 | 277K | 55.0K | SEC |
| 2026-06-17 | 06-18 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 5.5K | 60.81 | 334K | 59.5K | SEC |
| 2026-06-16 | 06-18 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 5.3K | 59.97 | 318K | 69.7K | SEC |
| 2026-06-16 | 06-18 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 4.7K | 60.71 | 285K | 65.0K | SEC |
| 2026-06-15 | 06-17 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 5.5K | 60.71 | 336K | 15.4K | SEC |
| 2026-05-19 | 05-21 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 199 | 65.51 | 13K | 21.0K | SEC |
| 2026-05-19 | 05-21 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 444 | 65.51 | 29K | 75.0K | SEC |
| 2026-02-18 | 02-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 423 | 73.00 | 31K | 75.5K | SEC |
| 2026-02-18 | 02-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 180 | 73.00 | 13K | 21.2K | SEC |
| 2026-01-20 | 01-22 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 3.9K | 35.67 | 138K | 21.4K | SEC |
| 2025-12-22 | 12-23 | Zalevsky Jonathan | Chief R&D Officer | A 獲配股票 | 6.3K | – | – | 25.2K | SEC |
| 2025-12-22 | 12-23 | ROBIN HOWARD W | President & CEO | A 獲配股票 | 21.7K | – | – | 75.9K | SEC |
| 2025-11-25 | 11-25 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 1.2K | 54.28 | 63K | 19.0K | SEC |
| 2025-11-25 | 11-25 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 630 | 54.28 | 34K | 21.6K | SEC |
| 2025-11-25 | 11-25 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 2.2K | 54.28 | 120K | 54.2K | SEC |
| 2025-11-21 | 11-25 | Zalevsky Jonathan | Chief R&D Officer | A 獲配股票 | 2.7K | – | – | 20.1K | SEC |
| 2025-11-21 | 11-25 | Wilson Mark Andrew | Chief Legal Officer | A 獲配股票 | 1.9K | – | – | 22.2K | SEC |
| 2025-11-21 | 11-25 | ROBIN HOWARD W | President & CEO | A 獲配股票 | 7.1K | – | – | 56.5K | SEC |
| 2025-09-09 | 09-11 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 2.2K | 47.49 | 102K | 50.6K | SEC |
| 2025-09-09 | 09-11 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 2.1K | 45.16 | 95K | 53.9K | SEC |
| 2025-09-09 | 09-11 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.2K | 48.18 | 58K | 49.3K | SEC |
| 2025-09-09 | 09-11 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.2K | 46.41 | 56K | 52.7K | SEC |
| 2025-09-05 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 2.2K | 38.82 | 86K | 57.1K | SEC |
| 2025-09-05 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 3.3K | 37.87 | 125K | 59.4K | SEC |
| 2025-09-05 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.1K | 39.89 | 45K | 56.0K | SEC |
| 2025-09-04 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 613 | 34.40 | 21K | 63.8K | SEC |
| 2025-09-04 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.1K | 35.80 | 41K | 62.7K | SEC |
| 2025-09-04 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.5K | 33.54 | 50K | 64.4K | SEC |
| 2025-09-04 | 09-08 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 432 | 33.60 | 15K | 18.0K | SEC |
| 2025-09-04 | 09-08 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 793 | 32.43 | 26K | 18.4K | SEC |
| 2025-09-04 | 09-08 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.9K | 32.37 | 62K | 65.9K | SEC |
| 2025-09-04 | 09-08 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 307 | 35.69 | 11K | 17.5K | SEC |
| 2025-09-04 | 09-08 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 189 | 34.41 | 7K | 17.8K | SEC |
| 2025-09-02 | 09-04 | ROBIN HOWARD W | President & CEO | S 公開市場賣出(10b5-1) | 1.5K | 30.16 | 45K | 67.8K | SEC |
| 2025-09-02 | 09-04 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出(10b5-1) | 485 | 30.10 | 15K | 19.2K | SEC |
| 2025-08-19 | 08-21 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 1.6K | 26.59 | 42K | 69.3K | SEC |
| 2025-08-19 | 08-21 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 725 | 26.59 | 19K | 19.7K | SEC |
| 2025-08-19 | 08-21 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 676 | 26.59 | 18K | 20.3K | SEC |
| 2025-05-19 | 05-21 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 10.7K | 0.67 | 7K | 306K | SEC |
| 2025-05-19 | 05-21 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 10.0K | 0.67 | 7K | 314K | SEC |
| 2025-05-19 | 05-21 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 23.2K | 0.67 | 16K | 1.1M | SEC |
| 2025-02-19 | 02-21 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 23.8K | 1.01 | 24K | 1.1M | SEC |
| 2025-02-19 | 02-21 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 10.3K | 1.01 | 10K | 317K | SEC |
| 2025-02-19 | 02-21 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 11.0K | 1.01 | 11K | 324K | SEC |
| 2024-12-24 | 12-26 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 16.6K | 0.89 | 15K | 335K | SEC |
| 2024-12-23 | 12-26 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 33.4K | 0.90 | 30K | 352K | SEC |
| 2024-12-19 | 12-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 51.1K | 0.94 | 48K | 327K | SEC |
| 2024-12-18 | 12-19 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 85.0K | 0.99 | 84K | 1.1M | SEC |
| 2024-12-17 | 12-19 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 47.0K | 1.01 | 47K | 1.2M | SEC |
| 2024-12-13 | 12-17 | Wilson Mark Andrew | Chief Legal Officer | A 獲配股票 | 166K | – | – | 385K | SEC |
| 2024-12-13 | 12-17 | ROBIN HOWARD W | President & CEO | A 獲配股票 | 411K | – | – | 1.2M | SEC |
| 2024-12-13 | 12-17 | Zalevsky Jonathan | Chief R&D Officer | A 獲配股票 | 135K | – | – | 378K | SEC |
| 2024-11-19 | 11-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 16.3K | 1.01 | 16K | 832K | SEC |
| 2024-11-19 | 11-20 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 6.4K | 1.01 | 6K | 219K | SEC |
| 2024-11-19 | 11-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 7.8K | 1.01 | 8K | 243K | SEC |
| 2024-08-19 | 08-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 6.9K | 1.28 | 9K | 251K | SEC |
| 2024-08-19 | 08-20 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 5.7K | 1.28 | 7K | 225K | SEC |
| 2024-08-19 | 08-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 14.9K | 1.28 | 19K | 848K | SEC |
| 2024-06-14 | 06-14 | CHESS ROBERT | Director | S 公開市場賣出(10b5-1) | 19.5K | 1.20 | 23K | 255K | SEC |
| 2024-05-17 | 05-20 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 6.3K | 1.75 | 11K | 230K | SEC |
| 2024-05-17 | 05-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 7.4K | 1.75 | 13K | 258K | SEC |
| 2024-05-17 | 05-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 16.6K | 1.75 | 29K | 863K | SEC |
| 2024-05-10 | 05-13 | Deep Track Biotechnology Master Fund, Ltd. | TenPercentOwner | S 公開市場賣出 | 56.0K | 1.78 | 100K | 18.3M | SEC |
| 2024-05-10 | 05-13 | Deep Track Capital, LP | TenPercentOwner | S 公開市場賣出 | 56.0K | 1.78 | 100K | 18.3M | SEC |
| 2024-05-10 | 05-13 | KROIN DAVID | TenPercentOwner | S 公開市場賣出 | 56.0K | 1.78 | 100K | 18.3M | SEC |
| 2024-02-20 | 02-22 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 9.0K | 0.68 | 6K | 265K | SEC |
| 2024-02-20 | 02-22 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 7.6K | 0.68 | 5K | 237K | SEC |
| 2024-02-20 | 02-22 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 20.0K | 0.68 | 14K | 880K | SEC |
| 2023-11-17 | 11-20 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 7.2K | 0.49 | 4K | 244K | SEC |
| 2023-11-17 | 11-20 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 19.9K | 0.49 | 10K | 900K | SEC |
| 2023-11-17 | 11-20 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 9.6K | 0.49 | 5K | 274K | SEC |
| 2023-09-18 | 09-20 | Curet Myriam | Director | S 公開市場賣出 | 4.4K | 0.69 | 3K | 27.4K | SEC |
| 2023-09-18 | 09-20 | Ajer Jeffrey Robert | Director | S 公開市場賣出 | 4.4K | 0.69 | 3K | 34.2K | SEC |
| 2023-08-16 | 08-17 | Zalevsky Jonathan | Chief R&D Officer | S 公開市場賣出 | 9.7K | 0.78 | 8K | 284K | SEC |
| 2023-08-16 | 08-17 | Wilson Mark Andrew | Chief Legal Officer | S 公開市場賣出 | 7.2K | 0.78 | 6K | 251K | SEC |
| 2023-08-16 | 08-17 | ROBIN HOWARD W | President & CEO | S 公開市場賣出 | 20.0K | 0.78 | 16K | 920K | SEC |
| 2023-06-14 | 06-15 | WHITFIELD ROY A | Director | S 公開市場賣出(10b5-1) | 30.0K | 0.57 | 17K | 216K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| FMR LLC | 5.1M | 354M | 新進 | 新進 |
| Two Seas Capital LP | 3.1M | 216M | 新進 | 新進 |
| BlackRock, Inc. | 2.9M | 205M | 新進 | 新進 |
| BVF INC/IL | 2.4M | 167M | 新進 | 新進 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | 104M | 新進 | 新進 |
| Two Sigma TWO SIGMA INVESTMENTS, LP | 1.2M | 83.9M | 新進 | 新進 |
| Vestal Point Capital, LP | 1.0M | 69.8M | 新進 | 新進 |
| MORGAN STANLEY | 937K | 65.4M | 新進 | 新進 |
| STATE STREET CORP | 910K | 63.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 881K | 61.5M | 新進 | 新進 |
| Prosight Management, LP | 810K | 56.5M | 新進 | 新進 |
| ARMISTICE CAPITAL, LLC | 724K | 50.5M | 新進 | 新進 |
| GILDER GAGNON HOWE & CO LLC | 601K | 41.9M | 新進 | 新進 |
| 千禧 MILLENNIUM MANAGEMENT LLC | 478K | 33.4M | 新進 | 新進 |
| BRAIDWELL LP | 474K | 33.1M | 新進 | 新進 |
| Sofinnova Investments, Inc. | 472K | 32.9M | 新進 | 新進 |
| Woodline Partners LP | 471K | 32.9M | 新進 | 新進 |
| ORBIMED ADVISORS LLC | 465K | 32.5M | 新進 | 新進 |
| UBS Group AG | 428K | 29.9M | 新進 | 新進 |
| EMERALD ADVISERS, LLC | 390K | 27.2M | 新進 | 新進 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 349K | 24.3M | 新進 | 新進 |
| DAFNA Capital Management LLC | 318K | 22.2M | 新進 | 新進 |
| NORTHERN TRUST CORP | 309K | 21.5M | 新進 | 新進 |
| Deep Track Capital, LP | 300K | 20.9M | 新進 | 新進 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 285K | 19.9M | 新進 | 新進 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 240 +32 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 240 / 0 / 0 / 0 |
| 機構合計持股 · 佔流通股 | 35.9M · 100.0% |
| 合計季末市值 | 2.5B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 6.1M |
|---|---|
| 與上期比 | -1.6% |
| 佔流通股數 | 17.77% |
| 日均成交量 | 530K |
| 回補天數 | 11.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 6.1M | -1.6% | 17.77% | 530K | 11.5 |
| 2026-08-14 | 6.2M | -2.1% | 18.07% | 592K | 10.4 |
| 2026-07-31 | 6.3M | -7.6% | 18.46% | 731K | 8.6 |
| 2026-07-15 | 6.8M | -1.1% | 19.97% | 978K | 7.0 |
| 2026-06-30 | 6.9M | +39.5% | 20.20% | 1.5M | 4.5 |
| 2026-06-15 | 4.9M | +7.2% | 14.48% | 1.0M | 4.9 |
| 2026-05-29 | 4.6M | +5.6% | 13.51% | 868K | 5.3 |
| 2026-05-15 | 4.4M | +6.5% | 12.79% | 838K | 5.2 |
| 2026-04-30 | 4.1M | +13.0% | 12.02% | 1.7M | 2.5 |
| 2026-04-15 | 3.6M | -0.9% | 10.63% | 628K | 5.8 |
| 2026-03-31 | 3.7M | -0.2% | 10.73% | 845K | 4.3 |
| 2026-03-13 | 3.7M | +9.8% | 10.75% | 969K | 3.8 |
| 2026-02-27 | 3.3M | -4.3% | 9.79% | 976K | 3.4 |
| 2026-02-13 | 3.5M | +6.2% | 10.22% | 2.2M | 1.6 |
| 2026-01-30 | 3.3M | +0.7% | 9.63% | 710K | 4.6 |
| 2026-01-15 | 3.3M | +11.2% | 9.56% | 700K | 4.7 |
| 2025-12-31 | 2.9M | +52.3% | 8.60% | 1.3M | 2.3 |
| 2025-12-15 | 1.9M | +6.0% | 5.64% | 582K | 3.3 |
| 2025-11-28 | 1.8M | +0.3% | 5.33% | 619K | 2.9 |
| 2025-11-14 | 1.8M | +23.2% | 5.31% | 756K | 2.4 |
| 2025-10-31 | 1.5M | -15.0% | 4.31% | 936K | 1.6 |
| 2025-10-15 | 1.7M | -12.1% | 5.07% | 717K | 2.4 |
| 2025-09-30 | 2.0M | +22.6% | 5.77% | 1.3M | 1.5 |
| 2025-09-15 | 1.6M | +44.0% | 4.71% | 1.6M | 1.0 |
| 2025-08-29 | 1.1M | +8.0% | 3.27% | 593K | 1.9 |
| 2025-08-15 | 1.0M | +0.8% | 3.03% | 695K | 1.5 |